Glycostem CDO Volker Huppert will be speaking at Cell Series UK conference on 7th - 8th November, 2022.
Glycostem to participate 22nd Annual Biotech in Europe Forum (BEF), in-person event on 21st-22nd of September 2022 at Basel, Switzerland.
Glycostem will participate EHA2022 Congress in Vienna from 9th to 12th June 2022.
Glycostem is going to participate Advanced Therapies Congress in London on 24th May, 2022. Meet us in the following session:
Time: 14:10 GMT +1
Presentation: Manufacturing genetically modified NK cells
Glycostem Chief Development Officer Volker Huppert is going to present at the 2022 BioProcess International Europe on 17th May, 2022.
Presentation title: Platform Approaches for Process Understanding Across Different Biopharmaceutical Sectors: Varying Starting Raw Material in ATMP Processes
Session: Cell & Gene Therapy
Time and date: Tuesday, 17th May 2022 14:15 - 14:45 CET
Glycostem is attending Bio€quity Europe 2022, from the 16th - 18th May 2022.
To book one-to-one partnering meeting with our CEO Troels Jordansen, search "Glycostem" in the partnering platform.